Optimizing Medication Safety with Oral Antitumor Therapy: A Methodological Approach for the Real-World Implementation of the AMBORA Competence and Consultation Center

por Cuba, Lisa, Schlichtig, Katja, Dürr, Pauline, Inwald, Elisabeth C., Fromm, Martin F., Dörje, Frank
Publicado 2023

Characteristics and Cost of Unscheduled Hospitalizations in Patients Treated with New Oral Anticancer Drugs in Germany: Evidence from the Randomized AMBORA Trial

por Dürr, Pauline, Meier, Florian, Schlichtig, Katja, Schramm, Anja, Schötz, Lukas, Fromm, Martin F., Dörje, Frank
Publicado 2022

New Oral Antitumor Drugs and Medication Safety in Uro-Oncology: Implications for Clinical Practice Based on a Subgroup Analysis of the AMBORA Trial

por Schlichtig, Katja, Cuba, Lisa, Dürr, Pauline, Bellut, Laura, Meidenbauer, Norbert, Kunath, Frank, Goebell, Peter J., Mackensen, Andreas, Dörje, Frank, Fromm, Martin F., Wullich, Bernd
Publicado 2022

An Easily Expandable Multi-Drug LC-MS Assay for the Simultaneous Quantification of 57 Oral Antitumor Drugs in Human Plasma

por Kehl, Niklas, Schlichtig, Katja, Dürr, Pauline, Bellut, Laura, Dörje, Frank, Fietkau, Rainer, Pavel, Marianne, Mackensen, Andreas, Wullich, Bernd, Maas, Renke, Fromm, Martin F., Gessner, Arne, Taudte, R. Verena
Publicado 2021